Latest news
CRC 1530 Seminar Series: Maximilian Merz, MD
Speaker: Maximilian Merz, Memorial SloanKettering Cancer Center, New York
Host: Hyatt Balke-Want
More information coming soon.
CRC 1530 Seminar Series: Marc Schmidt-Supprian, PhD
Speaker: Marc Schmidt-Supprian, TranslaTUM - Center for translational Cancer Research, Technical University of Munich, Immunopathologie and Signal…
CRC 1403 x CRC 1530 Seminar: Peter Czabotar, PhD
CRC 1530 Retreat
More information coming soon.
CRC 1530 Retreat
More information coming soon.
CRC 1530 Seminar Series: Heinz Jacobs, PhD
We are excited to announce our next CRC 1530 seminar featuring Prof. Heinz Jacobs PhD, research group leader at the Netherlands Cancer Institute.
…
CRC 1530 Coffee Break ☕ with Kristie Bariboloka
Anh Thu: Hi Kristie, could you introduce yourself and share some details about your scientific background?
Kristie: Hi, my name's Kristie. I am an…
CRC 1530 Seminar Series: Heinz Jacobs, PhD
We are excited to announce our next CRC 1530 seminar featuring Prof. Heinz Jacobs PhD, research group leader at the Netherlands Cancer Institute.
…
CRC 1530 Coffee Break ☕ with Mila Daoud
K: Hi Mila, please introduce yourself, and tell us about your scientific background and your current research.
M: Hello, my name is Mila Daoud. I'm…
Cell death isn’t the end, it’s a crucial decision point
Congratulations to two CRC 1530 papers fresh of the press!
Latest news
With the new funding period just started, we are excited to share the most recent paper of CRC1530
Abstract:
Caspase-3 (CASP3) and caspase-7 (CASP7) are the two major…
CRC 1530 Coffee Break ☕ with Sebastian Scheich
Kristie: Hi Sebastian, could you tell us a bit about yourself and what you're…
New publication on overcoming fratricide in CD86-targeted CAR-T cell therapy
Abstract:
Despite its remarkable success in the treatment of several…